H-VNFNFNGL-OH

Ref. 3D-PP48966

Produktinformation

• Name: H-VNFNFNGL-OH

Beschreibung

Peptide H-VNFNFNGL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VNFNFNGL-OH include the following: Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein Y Zhi, GP Kobinger, H Jordan, K Suchma, SR Weiss - Virology, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682205000620 Effects of SARS-CoV-2 omicron BA. 1 spike mutations on T-cell epitopes in mice Y Wang, B Wang, Z Zhao, J Xu, Z Zhang, J Zhang - Viruses, 2023 - mdpi.comhttps://www.mdpi.com/1999-4915/15/3/763 MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Y Kim, X Zheng, K Eschke, MZ Chaudhry - Cellular & Molecular , 2022 - nature.comhttps://www.nature.com/articles/s41423-021-00814-5 A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease VK Baxter, EJ Anderson , SA Taft-Benz, K Olsen - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.02.22.481499.abstract SARS coronavirus vaccines protect against different coronaviruses T Dangi , N Palacio, S Sanchez, J Class - bioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.06.01.446491.abstract Combining spike-and nucleocapsid-based vaccines improves distal control of SARS-CoV-2 T Dangi , J Class, N Palacio, JM Richner - Cell reports, 2021 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(21)01108-6.pdf Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 SR Mackin, P Desai , BM Whitener , CE Karl, M Liu - Nature , 2023 - nature.comhttps://www.nature.com/articles/s41564-023-01359-1 Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2 SR Mackin, P Desai , BM Whitener , CE Karl, M Liu - bioRxiv, 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727771/ Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation S Sanchez, T Dangi , B Awakoaiye, N Irani, S Fourati - bioRxiv, 2024 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10942304/ Single MVA-SARS-2-ST/N vaccination rapidly protects K18-hACE2 mice against a lethal SARS-CoV-2 challenge infection S Clever, L Limpinsel, C Meyer zu Natrup - Viruses, 2024 - mdpi.comhttps://www.mdpi.com/1999-4915/16/3/417 Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 P Desai , CE Karl, B Ying, CY Liang, T Garcia-Salum - bioRxiv, 2024 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827110/ Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2 N Erez, H Achdout, Y Yahalom-Ronen - Current Issues in , 2023 - mdpi.comhttps://www.mdpi.com/1467-3045/45/10/502 TCR transgenic clone selection guided by immune receptor analysis and single cell RNA expression of polyclonal responders N Debeuf, S Lameire, M Vanheerswynghels, J Deckers - bioRxiv, 2024 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2024.03.27.586931.abstract The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice KTH Do, S Willenzon, J Ristenpart - Frontiers in Cellular , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580083/ A spike-ferritin nanoparticle vaccine induces robust innate immune activity and drives polyfunctional SARS-CoV-2-specific T cells JM Carmen, S Shrivastava , Z Lu, A Anderson - BioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.04.28.441763.abstract SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses JM Carmen, S Shrivastava , Z Lu , A Anderson - npj Vaccines, 2021 - nature.comhttps://www.nature.com/articles/s41541-021-00414-4 Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses J van Bergen, MGM Camps, IN Pardieck, D Veerkamp - JCI insight, 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721273/ A SARS CoV-2 nucleocapsid vaccine protects against distal viral dissemination J Class, T Dangi , JM Richner, P Penaloza-MacMaster - BioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.04.26.440920.abstract Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine G Agbayani, B Akache, TM Renner - European Journal of , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.202350620 Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection B Ying, TL Darling, P Desai , CY Liang, IP Dmitriev - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41590-024-01743-x A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ. 1.1 and XBB. 1.5 infection and disease in mice and hamsters B Ying, TL Darling, P Desai , CY Liang, IP Dmitriev - bioRxiv, 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187308/ mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies B Montoya, CR Melo-Silva , L Tang, S Kafle , P Lidskiy - Molecular Therapy, 2024 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(24)00236-3 Studies on the Role of Necroptosis Proteins RIPK3 and MLKL in Resistance to Viral Infection and on the Role of CD8 T-Cells Induced by mRNA-LNP Vaccines in B Montoya - 2023 - search.proquest.comhttps://search.proquest.com/openview/17724d106e9bd9adfb942eb054d86be2/1?pq-origsite=gscholar&cbl=18750&diss=y Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants B Kingstad-Bakke, W Lee - Proceedings of the , 2022 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2118312119 Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents B Bošnjak , I Odak , J Barros-Martins, I Sandrock - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.772240/full

• Marke: Biosynth